Qube Research & Technologies (QRT)
CEL

Qube Research & Technologies (QRT)’s Cellcom Israel, Ltd. CEL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CEL Stock Details CEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-29,210
Closed -$142K – 2625
2020
Q4 		$142K Buy
+29,210
New +$128K ﹤0.01% 1596

Other funds holding CEL

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CFG
CKW Financial Group Honolulu, Hawaii $917M AUM 18.41% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CEL Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Cellcom Israel, Ltd. (CEL) in Q1 2021, closing a stake of 29,210 shares — an estimated $142K sold.

Qube Research & Technologies (QRT) first reported a position in CEL in Q4 2020 and held it in 1 quarter. The position peaked at $142K in Q4 2020. 12 funds tracked by Wall St. Rank hold CEL as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Cellcom Israel, Ltd. position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 29,210 Cellcom Israel, Ltd. shares in Q1 2021, an estimated $142K.
  • Qube Research & Technologies (QRT) first reported a position in Cellcom Israel, Ltd. in Q4 2020 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Cellcom Israel, Ltd. position peaked at $142K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.